🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.

Several professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or prison.

Platform Reaction and Material Removal

Based on TikTok, the platform has removed violative content and banned associated keywords and search suggestions. The company said it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of slimming results, glowing reviews and detailed guides for mixing or administering at home.

Within minutes of joining one community, a vendor posted contact information, where most transactions take place. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.

Item Information and Pricing

Inside these communities, posts show dark colored parcels with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has already encountered individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to potentially significant health risks”.